Davide G. Berta

Davide G. Berta

Auto-generated profile, based on publicly available information

Davide G. Berta

Medicum/Department of Medical and Clinical Genetics, University of Helsinki, Helsinki 00014, Finland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in Nature
Verified
Journal Article
Closed access
PDF file
DBDavide G. Berta
Davide G. Berta
HKHeli Kuisma
Heli Kuisma
NVNiko Välimäki
Niko Välimäki
MRMaritta Räisänen
Maritta Räisänen
MJMaija Jäntti
Maija Jäntti
LALauri A. Aaltonen
Lauri A. Aaltonen

1 September 2015 in Cell Reports
Verified
Journal Article
Open access
TKTakaharu Kanno
Takaharu Kanno
DBDavide G. Berta
Davide G. Berta
CSCamilla Sjögren
Camilla Sjögren
The structural maintenance of chromosome (SMC) protein complexes cohesin and condensin and the Smc5/6 complex (Smc5/6) are crucial for chromosome dynamics and stability. All contain essential ATPase domains, and cohesin and condensin interact with chromosomes through topological entrapment of DNA. However, how Smc5/6 binds DNA and chromosomes has remained largely unknown. Here, we show that purified Smc5/6 binds DNA through a mechanism that requires ATP hydrolysis by the complex and circular DNA to be established. This also promotes topoisomerase 2-dependent catenation of plasmids, suggesting that Smc5/6 interconnects two DNA molecules using ATP-regulated topological entrapment of DNA, similar to cohesin. We also show that a complex containing an Smc6 mutant that is defective in ATP binding fails to interact with DNA and chromosomes and leads to cell death with concomitant accumulation of DNA damage when overexpressed. Taken together, these results indicate that Smc5/6 executes its cellular functions through ATP-regulated intermolecular DNA linking.

19 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
EKEevi Kaasinen
Eevi Kaasinen
OKOuti Kuismin
Outi Kuismin
KRKristiina Rajamäki
Kristiina Rajamäki
HRHeikki Ristolainen
Heikki Ristolainen
MAMervi Aavikko
Mervi Aavikko
LALauri A. Aaltonen
Lauri A. Aaltonen
Clonal hematopoiesis driven by somatic heterozygous TET2 loss is linked to malignant degeneration via consequent aberrant DNA methylation, and possibly to cardiovascular disease via increased cytokine and chemokine expression as reported in mice. Here, we discover a germline TET2 mutation in a lymphoma family. We observe neither unusual predisposition to atherosclerosis nor abnormal pro-inflammatory cytokine or chemokine expression. The latter finding is confirmed in cells from three additional unrelated TET2 germline mutation carriers. The TET2 defect elevates blood DNA methylation levels, especially at active enhancers and cell-type specific regulatory regions with binding sequences of master transcription factors involved in hematopoiesis. The regions display reduced methylation relative to all open chromatin regions in four DNMT3A germline mutation carriers, potentially due to TET2-mediated oxidation. Our findings provide insight into the interplay between epigenetic modulators and transcription factor activity in hematological neoplasia, but do not confirm the putative role of TET2 in atherosclerosis.

16 October 2014 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
KJKristian Jeppsson
Kristian Jeppsson
KCKristian K. Carlborg
Kristian K. Carlborg
RNRyuichiro Nakato
Ryuichiro Nakato
DBDavide G. Berta
Davide G. Berta
ILIngrid Lilienthal
Ingrid Lilienthal
CSCamilla Sjögren
Camilla Sjögren
The cohesin complex, which is essential for sister chromatid cohesion and chromosome segregation, also inhibits resolution of sister chromatid intertwinings (SCIs) by the topoisomerase Top2. The cohesin-related Smc5/6 complex (Smc5/6) instead accumulates on chromosomes after Top2 inactivation, known to lead to a buildup of unresolved SCIs. This suggests that cohesin can influence the chromosomal association of Smc5/6 via its role in SCI protection. Using high-resolution ChIP-sequencing, we show that the localization of budding yeast Smc5/6 to duplicated chromosomes indeed depends on sister chromatid cohesion in wild-type and top2-4 cells. Smc5/6 is found to be enriched at cohesin binding sites in the centromere-proximal regions in both cell types, but also along chromosome arms when replication has occurred under Top2-inhibiting conditions. Reactivation of Top2 after replication causes Smc5/6 to dissociate from chromosome arms, supporting the assumption that Smc5/6 associates with a Top2 substrate. It is also demonstrated that the amount of Smc5/6 on chromosomes positively correlates with the level of missegregation in top2-4, and that Smc5/6 promotes segregation of short chromosomes in the mutant. Altogether, this shows that the chromosomal localization of Smc5/6 predicts the presence of the chromatid segregation-inhibiting entities which accumulate in top2-4 mutated cells. These are most likely SCIs, and our results thus indicate that, at least when Top2 is inhibited, Smc5/6 facilitates their resolution. When cells divide, sister chromatids have to be segregated away from each other for the daughter cells to obtain a correct set of chromosomes. Using yeast as model organism, we have analyzed the function of the cohesin and the Smc5/6 complexes, which are essential for chromosome segregation. Cohesin is known to hold sister chromatid together until segregation occurs, and our results show that cohesin also controls Smc5/6, which is found to associate to linked chromatids specifically. In line with this, our analysis points to that the chromosomal localization of Smc5/6 is an indicator of the level of entanglement between sister chromatids. When Smc5/6 is non-functional, the resolution of these entanglements is shown to be inhibited, thereby preventing segregation of chromatids. Our results also indicate that DNA entanglements are maintained on chromosomes at specific sites until segregation. In summary, we uncover new functions for cohesin, in regulating when and where Smc5/6 binds to chromosomes, and for the Smc5/6 complex in facilitating the resolution of sister chromatid entanglements.

28 January 2013 in Leukemia
Verified
Journal Article
Closed access
LML Mirandola
L Mirandola
LAL Apicella
L Apicella
MCMichela Colombo
Michela Colombo
YYY Yu
Y Yu
DBD G Berta
D G Berta
Raffaella ChiaramonteRaffaella Chiaramonte
Raffaella Chiaramonte

10 July 2026 in Science Advances
Verified
Journal Article
Open access
MLMarika Lassila
Marika Lassila
FSFatemeh Seyednasrollah
Fatemeh Seyednasrollah
CBCinzia Bessone
Cinzia Bessone
MRMaritta Räisänen
Maritta Räisänen
IVInkeri Vuori
Inkeri Vuori
PKPauliina Kallio
Pauliina Kallio
Plasticity, the capability of tumor cells to go through phenotypic transitions, promotes colorectal cancer (CRC) progression and treatment resistance. Although plasticity is evident in advanced CRCs, little is known about plasticity in early-stage tumors and tumor stem cells. Here, we demonstrate that a plastic cell state (PCS) is present already in polyps from patients with familial adenomatous polyposis and in mouse intestinal adenomas, in which PCS is associated with PROX1 + tumor stem cells. We furthermore analyzed progressive plasticity upon loss of the canonical wingless-related integration site (Wnt) effector Tcf7 or Lef1 in Apc mutant mice. Deletion of either gene led to emergence of new plastic tumor cell populations, failure of leucine-rich repeat–containing G protein-coupled receptor 5 (Lgr5) tumor stem cell differentiation into enterocyte-like cells, enhanced Myc pathway activation, and increased tumor cell proliferation and tumorigenesis. Together, we demonstrate that PCS is associated with early CRC development and identify multiple potentially druggable mechanisms activated during progressive tumor cell plasticity.